Berman McAleer’s Immuneering IMRX Stock Holding History

Berman McAleer’s Portfolio IMRX Stock Details IMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$125K	Hold	25,000	–	–	0.01%	174
2026 Q1	$132K	Hold	25,000	–	–	0.02%	160
2025 Q4	$165K	Hold	25,000	–	–	0.02%	160
2025 Q3	$175K	Buy	+25,000	New	+$130K	0.02%	164

Other funds holding IMRX

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

FCC

Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

FFN

Focus Financial Network Minneapolis, Minnesota $3.23B AUM 29.61% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Berman McAleer's IMRX Position: Q2 2026 in Review

Berman McAleer held its Immuneering (IMRX) position steady in Q2 2026 at 25,000 shares worth $125K. The position accounts for 0.01% of the portfolio, ranked #174.

Berman McAleer first reported a position in IMRX in Q3 2025 and has held it in 4 quarters since. The position peaked at $175K in Q3 2025. 6 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

Berman McAleer held 25,000 shares of Immuneering worth $125K as of Q2 2026.
Berman McAleer left its Immuneering share count unchanged in Q2 2026.
Immuneering made up 0.01% of Berman McAleer's portfolio in Q2 2026, its #174 holding.
Berman McAleer first reported a position in Immuneering in Q3 2025 and has held it in 4 quarters since.
Berman McAleer's Immuneering position peaked at $175K in Q3 2025.
6 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Berman McAleer's 13F filing for Q2 2026, filed 16 Jul 2026.